Karlberg I, Nyberg G
University of Göteborg, Sweden.
Int J Technol Assess Health Care. 1995 Summer;11(3):611-22. doi: 10.1017/s026646230000876x.
This study analyzes opportunity costs for the treatment of end-stage renal disease. Kidney transplantation remains the most cost-effective treatment for uremia and is one of the most cost-effective technologies in health care. Improved survival of grafts and increased numbers of transplants have the potential to reduce costs for dialysis programs. To support organ donation activities, the public and concerned health professionals should be informed about the opportunity cost of "unnecessary" dialysis. These resources could be reallocated from dialysis to other programs. Among patients in dialysis, a more common use of chronic ambulatory peritoneal dialysis instead of institution-based hemodialysis would greatly increase cost-utility and further reduce the program costs of renal replacement therapy.
本研究分析了终末期肾病治疗的机会成本。肾移植仍然是治疗尿毒症最具成本效益的方法，也是医疗保健领域最具成本效益的技术之一。移植肾存活率的提高和移植数量的增加有可能降低透析项目的成本。为了支持器官捐赠活动，应该向公众和相关医疗专业人员宣传“不必要”透析的机会成本。这些资源可以从透析重新分配到其他项目。在透析患者中，更普遍地使用持续性非卧床腹膜透析而非机构性血液透析将极大地提高成本效益，并进一步降低肾脏替代治疗的项目成本。
